Internal Medicine, Hematology · Hollywood, FL
NPI
1619234242
Since 2012
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3700 Johnson St, Suite B
Hollywood, FL, 33021
Phone (954) 265-1400
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
187 services
Medicare patients, 2024
36
Average age 37
Drug cost, 2024
$592K
1,158 prescriptions
Company payments, 2025
$85.44
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Foluso Ogunsile was code 99213 (office e&m - established), 55 times for 25 patients. In total Foluso Ogunsile billed 187 services in 8 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 55 | 25 | $47.57 | $2,617 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 42 | 22 | $13.18 | $554 |
By year: 2022 $9,359 for 132 services; 2023 $18K for 229 services; 2024 $10K for 187 services.
Medicare prescription drug claims, 2024
In 2024, the drug Foluso Ogunsile prescribed most often to Medicare patients was Oxycodone Hcl, with 273 prescriptions and refills. In total Foluso Ogunsile wrote 1,158 Medicare prescriptions that cost $592K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 273 | 273 | 34 | $6,098 |
| Hydromorphone Hcl Generic | 101 | 101 | Under 11 | $591 |
| Hydroxyurea Generic | 100 | 128 | 26 | $2,586 |
| Morphine Sulfate Er Morphine Sulfate | 99 | 99 | 11 | $3,788 |
| Oxycontin Oxycodone Hcl | 47 | 47 | Under 11 | $55K |
| Cyclobenzaprine Hcl Generic | 38 | 39 | Under 11 | $357 |
| Methadone Hcl Generic | 37 | 37 | Under 11 | $941 |
| Deferasirox Generic | 35 | 35 | Under 11 | $36K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 29 | 29 | Under 11 | $679 |
| Gabapentin Generic | 27 | 37 | Under 11 | $358 |
| Ibuprofen Generic | 25 | 29 | Under 11 | $123 |
| Morphine Sulfate Generic | 24 | 24 | Under 11 | $880 |
| Xtampza Er Oxycodone Myristate | 22 | 22 | Under 11 | $21K |
| Endari Glutamine | 19 | 19 | Under 11 | $62K |
| Oxbryta Voxelotor | 18 | 18 | Under 11 | $200K |
Brand drugs: 158 claims; generic drugs: 1,000 claims; opioid claims: 639.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Foluso Ogunsile $85.44 ($85.44 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $85.44.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $85.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.